Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
5.86
0.00 (0.00%)
At close: Sep 26, 2025, 4:00 PM EDT
5.90
+0.04 (0.68%)
After-hours: Sep 26, 2025, 8:00 PM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $147.66 million as of September 26, 2025. Its market cap has decreased by -6.12% in one year.
Market Cap
147.66M
Enterprise Value
73.47M
1-Year Change
-6.12%
Ranking
Category
Stock Price
$5.86
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $147.66M, an increase of 62.09%. That is a compound annual growth rate of 10.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 147.66M | -16.30% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 665.99B |
| Johnson & Johnson | 425.53B |
| AbbVie | 388.63B |
| UnitedHealth Group | 318.63B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 233.03B |